Mesa Laboratories Stock Analysis

MLAB Stock  USD 90.59  2.02  2.28%   
Below is the normalized historical share price chart for Mesa Laboratories extending back to February 29, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mesa Laboratories stands at 90.59, as last reported on the 17th of February 2026, with the highest price reaching 92.15 and the lowest price hitting 88.38 during the day.
IPO Date
25th of January 1995
200 Day MA
82.9248
50 Day MA
83.111
Beta
0.891
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Mesa Laboratories holds a debt-to-equity ratio of 0.569. At present, Mesa Laboratories' Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 219.1 M, whereas Long Term Debt is forecasted to decline to about 87.5 M. With a high degree of financial leverage come high-interest payments, which usually reduce Mesa Laboratories' Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Mesa Laboratories' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Mesa Laboratories' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Mesa Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Mesa Laboratories' stakeholders.
For many companies, including Mesa Laboratories, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Mesa Laboratories, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Mesa Laboratories' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
2.6806
Enterprise Value Ebitda
13.1273
Price Sales
2.0219
Shares Float
5.4 M
Dividend Share
0.64
At present, Mesa Laboratories' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 523.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 4.3 M. . At present, Mesa Laboratories' Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 3.97, whereas Price Earnings Ratio is projected to grow to (279.03).
Mesa Laboratories is undervalued with Real Value of 95.2 and Target Price of 104.5. The main objective of Mesa Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Mesa Laboratories is worth, separate from its market price. There are two main types of Mesa Laboratories' stock analysis: fundamental analysis and technical analysis.
The Mesa Laboratories stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mesa Laboratories' ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

Mesa Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The book value of Mesa Laboratories was now reported as 33.79. The company has Price/Earnings (P/E) ratio of 433.94. Mesa Laboratories last dividend was issued on the 27th of February 2026. Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. Mesa Labs operates under Scientific Technical Instruments classification in the United States and is traded on NASDAQ Exchange. It employs 681 people. To find out more about Mesa Laboratories contact the company at 303 987 8000 or learn more at https://www.mesalabs.com.

Mesa Laboratories Quarterly Total Revenue

65.13 Million

Mesa Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mesa Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mesa Laboratories or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 154.48 M.
Over 85.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Mesa Laboratories, Inc.s Stock Going Strong But Fundamentals Look Weak What Implications Could This Have On The Stock

Mesa Largest EPS Surprises

Earnings surprises can significantly impact Mesa Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-02-06
2022-12-310.140.08-0.0642 
2023-08-03
2023-06-30-0.02-0.1-0.08400 
2013-08-06
2013-06-300.610.52-0.0914 
View All Earnings Estimates

Mesa Laboratories Environmental, Social, and Governance (ESG) Scores

Mesa Laboratories' ESG score is a quantitative measure that evaluates Mesa Laboratories' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mesa Laboratories' operations that may have significant financial implications and affect Mesa Laboratories' stock price as well as guide investors towards more socially responsible investments.

Mesa Stock Institutional Investors

Shares
Hhg Plc2025-06-30
113.3 K
Select Equity Group Lp2025-06-30
102.2 K
Northern Trust Corp2025-06-30
92.7 K
Kennedy Capital Management Inc2025-06-30
90.5 K
Acadian Asset Management Llc2025-06-30
79.5 K
Ameriprise Financial Inc2025-06-30
73.5 K
Renaissance Technologies Corp2025-06-30
68 K
Bank Of America Corp2025-06-30
64.9 K
Charles Schwab Investment Management Inc2025-06-30
61.8 K
Blackrock Inc2025-06-30
791.1 K
Conestoga Capital Advisors, Llc2025-06-30
566.1 K
Note, although Mesa Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mesa Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 500.49 M.

Mesa Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed 0.07  0.07 
Return On Equity(0.01)(0.01)

Management Efficiency

Mesa Laboratories has return on total asset (ROA) of 0.0247 % which means that it generated a profit of $0.0247 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0218 %, meaning that it created $0.0218 on every $100 dollars invested by stockholders. Mesa Laboratories' management efficiency ratios could be used to measure how well Mesa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.01. In addition to that, Return On Capital Employed is expected to decline to 0.07. At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 399.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 17.6 M.
Last ReportedProjected for Next Year
Book Value Per Share 26.50  27.82 
Tangible Book Value Per Share(25.17)(23.91)
Enterprise Value Over EBITDA 16.97  11.57 
Price Book Value Ratio 3.63  2.38 
Enterprise Value Multiple 16.97  11.57 
Price Fair Value 3.63  2.38 
Enterprise Value537.6 M564.5 M
Evaluating the management effectiveness of Mesa Laboratories allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Mesa Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Dividend Yield
0.0072
Operating Margin
0.1225
Profit Margin
0.0151
Forward Dividend Yield
0.0071
Beta
0.891

Technical Drivers

As of the 17th of February 2026, Mesa Laboratories secures the Downside Deviation of 2.45, risk adjusted performance of 0.0615, and Mean Deviation of 1.97. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mesa Laboratories, as well as the relationship between them.

Mesa Laboratories Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mesa Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mesa Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mesa Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mesa Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mesa Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mesa Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Sullivan John James over two months ago
Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3
 
Alltoft Jennifer Sadie over six months ago
Disposition of 1404 shares by Alltoft Jennifer Sadie of Mesa Laboratories subject to Rule 16b-3
 
Gary Owens over six months ago
Disposition of 3301 shares by Gary Owens of Mesa Laboratories subject to Rule 16b-3
 
John Sakys over six months ago
Disposition of 642 shares by John Sakys of Mesa Laboratories at 97.118 subject to Rule 16b-3
 
John Sakys over six months ago
Disposition of 793 shares by John Sakys of Mesa Laboratories subject to Rule 16b-3
 
Gary Owens over six months ago
Disposition of 1637 shares by Gary Owens of Mesa Laboratories subject to Rule 16b-3
 
Gary Owens over six months ago
Disposition of 99 shares by Gary Owens of Mesa Laboratories at 203.54 subject to Rule 16b-3
 
Brian Archbold over six months ago
Disposition of 386 shares by Brian Archbold of Mesa Laboratories at 133.69 subject to Rule 16b-3
 
Tripeny R Tony over six months ago
Acquisition by Tripeny R Tony of 1105 shares of Mesa Laboratories subject to Rule 16b-3
 
Schmieder John Bradley over six months ago
Disposition of 3000 shares by Schmieder John Bradley of Mesa Laboratories at 123.3217 subject to Rule 16b-3
 
Gary Owens over six months ago
Disposition of 21000 shares by Gary Owens of Mesa Laboratories at 123.91 subject to Rule 16b-3
 
Sullivan John James over a year ago
Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3

Mesa Laboratories Outstanding Bonds

Mesa Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mesa Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mesa bonds can be classified according to their maturity, which is the date when Mesa Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Mesa Laboratories Predictive Daily Indicators

Mesa Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mesa Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mesa Laboratories Corporate Filings

8K
3rd of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
5th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
6th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
31st of October 2025
An amended filing to the original Schedule 13G
ViewVerify
F4
28th of October 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
2nd of October 2025
An amended filing to the original Schedule 13G
ViewVerify
8K
25th of August 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
18th of August 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Mesa Laboratories Forecast Models

Mesa Laboratories' time-series forecasting models are one of many Mesa Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mesa Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mesa Laboratories Bond Ratings

Mesa Laboratories financial ratings play a critical role in determining how much Mesa Laboratories have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Mesa Laboratories' borrowing costs.
Piotroski F Score
6
HealthyView
Beneish M Score
(2.83)
Unlikely ManipulatorView

Mesa Laboratories Debt to Cash Allocation

As Mesa Laboratories follows its natural business cycle, the capital allocation decisions will not magically go away. Mesa Laboratories' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Mesa Laboratories currently holds 181.47 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Mesa Laboratories has a current ratio of 2.84, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Mesa Laboratories' use of debt, we should always consider it together with its cash and equity.

Mesa Laboratories Total Assets Over Time

Mesa Laboratories Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Mesa Laboratories uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Mesa Laboratories Debt Ratio

    
  19.0   
It appears most of the Mesa Laboratories' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Mesa Laboratories' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Mesa Laboratories, which in turn will lower the firm's financial flexibility.

Mesa Laboratories Corporate Bonds Issued

Most Mesa bonds can be classified according to their maturity, which is the date when Mesa Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Mesa Net Debt

Net Debt

186.14 Million

At present, Mesa Laboratories' Net Debt is projected to increase significantly based on the last few years of reporting.

About Mesa Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mesa Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mesa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mesa Laboratories. By using and applying Mesa Stock analysis, traders can create a robust methodology for identifying Mesa entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.03  0.03 
Operating Profit Margin 0.08  0.07 
Net Loss(0.01)(0.01)
Gross Profit Margin 0.72  0.69 

Current Mesa Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mesa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mesa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
104.5Buy4Odds
Mesa Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mesa analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mesa stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mesa Laboratories, talking to its executives and customers, or listening to Mesa conference calls.
Mesa Analyst Advice Details

Mesa Stock Analysis Indicators

Mesa Laboratories stock analysis indicators help investors evaluate how Mesa Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mesa Laboratories shares will generate the highest return on investment. By understating and applying Mesa Laboratories stock analysis, traders can identify Mesa Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow28.2 M
Long Term Debt76.9 M
Common Stock Shares Outstanding5.4 M
Total Stockholder Equity159.8 M
Total Cashflows From Investing Activities-4.5 M
Tax Provision7.9 M
Quarterly Earnings Growth Y O Y-0.287
Property Plant And Equipment Net32.3 M
Cash And Short Term Investments27.3 M
Cash27.3 M
Accounts Payable5.7 M
Net Debt154.2 M
50 Day M A83.111
Total Current Liabilities164 M
Other Operating Expenses224.6 M
Non Current Assets Total330.7 M
Forward Price Earnings35.2113
Non Currrent Assets Other18.3 M
Stock Based Compensation13.1 M

Complementary Tools for Mesa Stock analysis

When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity